Clicky

OraSure Technologies Inc(EP3)

Description: OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.


Keywords: Disease Antibodies HIV Diagnostic Tests Medical Test Diagnostic Products Blood Test HIV/Aids Analytical Services HCV Drug Test Rapid Diagnostic Test Diagnosis Of Hiv/Aids Microbiome Oraquick Orasure Technologies Q.E.D. Specimen Collection Devices

Home Page: www.orasure.com

220 East First Street
Bethlehem, PA 18015
United States
Phone: 610 882 1820


Officers

Name Title
Ms. Carrie Eglinton Manner President, CEO & Director
Mr. Kenneth J. McGrath Chief Financial Officer
Ms. Kathleen Gallagher Weber Chief Product Officer
Ms. Michele Anthony Senior VP, Chief Accounting Officer, Controller & Assistant Secretary
Mr. Rafal Iwasiow Ph.D. Vice President of Science, Innovation & Technology
Mr. Jason Michael Plagman Vice President of Investor Relations
Mr. Stefano Taucer General Counsel & Corporate Secretary
Mr. David A. Rappaport C.F.A. Senior Vice President Corporate Development, Strategy & Integration
Amy Steigerwalt Senior Vice President of Human Resources
Mr. Zachary Wert Senior Vice President of Global Operations

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 25.5714
Price-to-Book MRQ: 0.6642
Price-to-Sales TTM: 1.215
IPO Date:
Fiscal Year End: December
Full Time Employees: 638
Back to stocks